Sahajanand Medical Technologies IPO GMP today is Rs 20. Investors can use this GMP along with price band and subscription status for a better IPO review.
Closed
Mainboard IPO
SMT
Sahajanand Medical Technologies IPO GMP & Allotment
Sahajanand Medical Technologies develops, manufactures, and markets cardiovascular devices globally. The core business is divided into two primary segments: vascular intervention products, such as coronary stents and balloon catheters, and structural heart devices, including transcatheter aortic valves and occluders. The company generates the majority of its revenue from the sale of vascular intervention devices, with the Supraflex Cruz, a biodegradable polymer-based drug-eluting stent, acting as a major contributor to its sales. Products are distributed across India, Europe, and the rest of the world through a combination of direct, hybrid, and distributor-led models, supported by an extensive network of domestic and international distributors. Operations are backed by manufacturing facilities located in Surat, Hyderabad, and Thailand. Additionally, the business relies heavily on dedicated research and development capabilities to continually enhance existing products and introduce new cardiovascular treatments.
- IPO Price Band
- ₹327.00 - ₹344.00
- Lot Size
- 43 Shares
- Bidding Closes
- 19 Oct 2026
- Listing Date
- 23 Oct 2026
Current GMP Status
₹20
+5.81% vs upper band
Est. Listing Gain
+5.81%
Last Trend
21 Oct 2026
Listing Price
Est. ₹364
Retail Entry
₹14,792
IPO Details
Complete IPO information
| IPO Open Date | 15 Oct 2026 |
|---|---|
| IPO Close Date | 19 Oct 2026 |
| IPO Price Band | ₹327.00 - ₹344.00 |
| Lot Size | 43 Shares |
| Current GMP | ₹20 |
| Estimated Listing Gain | +5.81% |
| Issue Size | Approx ₹475.48 Cr |
| Fresh Issue | - |
| Issue Type | Mainboard |
| IPO Listing | BSE, NSE |
| Retail Quota | TBA |
| Registrar | MUFG Intime India Pvt. Ltd. |
| Overall Subscription | 4.29x |
| Minimum Investment | ₹14,792 |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |
Demand Tracker
Subscription Status
| Category | Shares Reserved | Shares Applied | Subscription (x) |
|---|---|---|---|
| QIB | 27.14 | 165.20 | 6.09x |
| NII | 20.36 | 174.31 | 8.56x |
| Retail | 47.50 | 78.11 | 1.64x |
| Overall Subscription | 97.50 | 418.11 | 4.29x |
Day-wise demand
Sahajanand Medical Technologies IPO subscription status day-wise
| Day | QIB | NII | Retail | Total |
|---|---|---|---|---|
| Day 3 (19 Oct) | 1.12x | 0.51x | 0.82x | 0.82x |
Subscription in times (x) at the end of each bidding day. Today's row updates through the day.
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Sahajanand Medical Technologies is priced at ₹344 per share. With a minimum lot size of 43 shares, a retail investor applying for one lot would need approximately ₹14,792 to participate in this Mainboard issue.
The latest recorded Grey Market Premium for Sahajanand Medical Technologies stands at ₹20, implying an estimated listing gain of around 5.81% over the issue price if it holds until listing. This is down ₹1 from its previously recorded level. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
As of the latest update, Sahajanand Medical Technologies's IPO was subscribed 4.29x overall, with a category-wise breakdown of Retail 1.64x, QIB 6.09x, NII 8.56x.
Mainboard IPOs list on the main platform of BSE/NSE, typically involve larger issue sizes, and draw participation across retail, HNI and institutional (QIB) investor categories.
Timeline
IPO roadmap at a glance
✓
Bidding Opens
15 Oct 2026
✓
Bidding Closes
19 Oct 2026
03
Allotment Next
21 Oct 2026
04
Listing
23 Oct 2026
Grey Market Premium
Daily GMP status
| Date | GMP | Change | Gain |
|---|---|---|---|
| 21 Oct 2026 | ₹24.00 | -₹1.00 | 6.98% |
| 20 Oct 2026 | ₹25.00 | - | 7.27% |
| 19 Oct 2026 | ₹25.00 | +₹10.00 | 7.27% |
| 17 Oct 2026 | ₹15.00 | -₹25.00 | 4.36% |
| 16 Oct 2026 | ₹40.00 | -₹5.00 | 11.63% |
| 15 Oct 2026 | ₹45.00 | +₹3.00 | 13.08% |
| 14 Oct 2026 | ₹42.00 | - | 12.21% |
| 13 Oct 2026 | ₹42.00 | -₹4.00 | 12.21% |
| 12 Oct 2026 | ₹46.00 | +₹6.00 | 13.37% |
| 11 Oct 2026 | ₹40.00 | - | 11.63% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 1 Lot | 43 | ₹14,792 |
| Retail Maximum | 13 Lot | 559 | ₹1,92,296 |
| S-HNI Minimum | 14 Lot | 602 | ₹2,07,088 |
| S-HNI Maximum | 67 Lot | 2,881 | ₹9,91,064 |
| B-HNI Minimum | 68 Lot | 2,924 | ₹10,05,856 |
Swipe to see more →
Fund Utilization
Objects of the Issue & Official Documents
Analysis
Sahajanand Medical Technologies IPO Dates
| Particular | Dates |
|---|---|
| IPO Open Date | 15 Oct 2026 |
| IPO Close Date | 19 Oct 2026 |
| Basis of Allotment | 21 Oct 2026 |
| Refunds | 22 Oct 2026 |
| Credit to Demat Account | 22 Oct 2026 |
| IPO Listing Date | 23 Oct 2026 |
Note: The timeline for Sahajanand Medical Technologies IPO is tentative and subject to change.
Analysis
Sahajanand Medical Technologies Objects of the Issue & Utilisation of Proceeds
To Be Updated Soon
Analysis
Sahajanand Medical Technologies Company Financials
| Period | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2024 | 908.59 Cr. | 875.50 Cr. | 7.35 Cr. | 970.58 Cr. |
| 2025 | 1,035.96 Cr. | 980.12 Cr. | 25.15 Cr. | 1,094.90 Cr. |
| 2026 | 1218.73 Cr. | 1138.43 Cr. | 69.08 Cr. | 1276.43 Cr. |
| June 2026 | 354.33 Cr. | 330.05 Cr. | 15.09 Cr. | 1308.100 Cr. |
Note: Financial numbers for Sahajanand Medical Technologies are in ₹ Crores unless stated otherwise.
Analysis
Sahajanand Medical Technologies Company Valuation – FY2026
| KPI | Values |
|---|---|
| ROE | -% |
| ROCE | 11.57% |
| EBITDA Margin | 14.10% |
| PAT Margin | 5.71% |
| Debt to Equity Ratio | – |
| Earning Per Share (EPS) | 6.67 (Basic) |
| Price/Earning P/E Ratio | - |
| Return on Net Worth (RoNW) | 10.60% |
| Net Asset Value (NAV) | 62.76 |
Note: Valuation KPIs for Sahajanand Medical Technologies are computed for FY2026.
Analysis
Sahajanand Medical Technologies IPO Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Poly Medicure Limited | 31.79 | 51.40 | 10.37% | 306.40 | 1875.26 Cr. |
| Laxmi Dental Limited | 5.27 | 36.35 | 11.91% | 44.27 | 277.86 Cr. |
Note: Peer group comparisons for Sahajanand Medical Technologies are sourced from DRHP filings.
Comparison
Compare Sahajanand Medical Technologies IPO with similar IPOs
FAQ
Sahajanand Medical Technologies IPO FAQs
Sahajanand Medical Technologies IPO price band is Rs 327.00 to Rs 344.00. Check the latest issue price, lot size and GMP together before applying.
Sahajanand Medical Technologies IPO open date is 15 Oct 2026, close date is 19 Oct 2026, and listing date is 23 Oct 2026.
Sahajanand Medical Technologies IPO lot size is 43 shares. The minimum retail investment is Rs 14,792.
Sahajanand Medical Technologies is classified as a Mainboard IPO. This helps investors quickly understand the issue category and exchange segment.
Sahajanand Medical Technologies IPO subscription status currently shows Retail 1.64x, QIB 6.09x, NII 8.56x, Overall 4.29x.
Sahajanand Medical Technologies develops, manufactures, and markets cardiovascular devices globally. The core business is divided into two primary segments: vascular intervention products, such as coronary stents and balloon catheters, and structural heart devices, including transcatheter aortic valves and occluders. The company generates the majority of its revenue from the sale of vascular intervention devices, with the Supraflex Cruz, a biodegradable polymer-based drug-eluting stent, acting as a major contributor to its sales. Products are distributed across India, Europe, and the rest of the world through a combination of direct, hybrid, and distributor-led models, supported by an extensive network of domestic and international distributors. Operations are backed by manufacturing facilities located in Surat, Hyderabad, and Thailand. Additionally, the business relies heavily on dedicated research and development capabilities to continually enhance existing products and introduce new cardiovascular treatments.
Sahajanand Medical Technologies IPO issue size is TBA and the expected allotment date is 21 Oct 2026.
Community discussion
Comments
Share a useful question or insight about Sahajanand Medical Technologies.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Keep Exploring
Similar Recent IPOs
Mainboard
Bombay Coated & Special Steels
Price BandTBA
Current GMP₹0
Lot SizeTBA
Mainboard
BLS Polymers
Price Band₹142.00 - ₹150.00
Current GMP₹29 · +19.3%
Lot Size100 Shares
Mainboard
SFC Environmental Technologies
Price Band₹313.00 - ₹330.00
Current GMP₹21 · +6.4%
Lot Size45 Shares
Mainboard
EAAA India Alternatives
Price Band₹1585.00 - ₹1665.00
Current GMP₹0
Lot Size9 Shares
Loading comments...